Company Search:
Advanced Search
Sponsored Links
Curative Biosciences Inc Company Snapshot
Curative Biosciences Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Curative Biosciences Inc with three other companies in this sector in the United States: Neuralstem, Incorporation. (2013 sales of $110,000.00 of which 100% was Stem Cell Technology), AIM ImmunoTech Inc ($150,000.00 of which 100% was Biomedical R & D), and CEL-SCI Corporation ($159,583.00 of which 100% was Pharmaceutical Products).

Sales Analysis. Curative Biosciences Inc reported sales of $161,954.00 for the fiscal year ending June of 2013. This represents a sharp decrease of 48.6% versus 2012, when the company's sales were $314,980.00 .
  Stock Performance Chart for Curative Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/3/2019): .38
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Curative Biosciences Inc Key Data:
  Ticker: CBDX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2013 Sales 161,954
(Year Ending Jan 2014).
Employees: 36
  Currency: U.S. Dollars Market Cap: 11,998,384
  Fiscal Yr Ends: June Shares Outstanding: 31,574,695
  Share Type: Common Closely Held Shares: 11,976,053
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.